403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Cell Harvesting Market To Reach USD 20.08 Billion, Growing At A Strong 12.95% CAGR By 2034
| Metric | Details | |
| Market Size in 2025 | USD 6.71 Billion | |
| Projected Market Size in 2034 | USD 20.08 Billion | |
| CAGR (2025 - 2034) | 12.95 | % |
| Leading Region | North America share by 43% | |
| Market Segmentation | By Product Type, By Cell Type, By Application, By Technique, By Region | |
| Top Key Players | Thermo Fisher Scientific Inc., Merck KGaA (MilliporeSigma), GE HealthCare (Cytiva), Sartorius AG, Eppendorf SE, BD Biosciences, Terumo BCT, Inc., Beckman Coulter Life Sciences (Danaher), Miltenyi Biotec GmbH, Fresenius Kabi (CompoFlex & LOVO systems), Corning Incorporated, Lonza Group AG, Repligen Corporation, Asahi Kasei Medical Co., Ltd., Stemcell Technologies Inc., PerkinElmer Inc. (Revvity), Bio-Rad Laboratories, Inc., PBS Biotech, Inc., Terumo Corporation, Applikon Biotechnology (a Getinge company) |
What are the Significant Drivers in the Cell Harvesting Market?
A rise in the incidence of chronic diseases, especially cancer, cardiovascular diseases, and autoimmune disorders, and the growing stem cell research cell-based therapies
What are the Prominent Trends in the Cell Harvesting Market?
- In September 2025, Pluristyx Inc. and BioLamina AB partnered to streamline, derisk, and escalate clinical translation of iPSC-based therapies. In June 2025, Celltrio secured $15 million in financial investment to elevate global growth in cell culturing and cell & gene therapy automation. In May 2025, the Maryland Stem Cell Research Commission awarded over $18 million in grants focused on escalating cutting-edge stem cell and regenerative medicine research across Maryland.
What is the Crucial Challenge in the Cell Harvesting Market?
The growing need for higher expenses for sophisticated technologies, as well as stricter and time-consuming regulatory approvals, the requirement for non-standardized protocols, and ethical issues, mainly stem cell research, are creating a major hurdle in the market expansion.
Regional Analysis
How did North America Dominate the Market in 2024?
In 2024, North America captured a major revenue share of 43% market. The presence of well-developed biotechnology and pharmaceutical sectors, vital investments in regenerative medicine, and cell-based research are driving the regional market growth. Supportive regulatory solutions, including the FDA's fast-track program for cell and gene therapiesFor instance,
- In October 2025, Relive Health and Dr. Adeel Khan partnered to leverage innovative muse cell therapy in the United States for the first time.
What Made the Asia Pacific Grow Significantly in the Market in 2024?
In the future, the Asia Pacific is anticipated to register the fastest growth in the cell harvesting market. A prominent catalyst is a robust government for research and development, specifically in China, Japan, and India, integrated with accelerated healthcare spending, which is boosting the adoption of advanced technologies. Whereas Chinese researchers are increasingly transforming modular 3D-printed microfluidic systems for continuous, large-scale harvesting of mesenchymal stem cells (MSCs) from microcarriers.
For instance,
- In October 2024, Sino-Biocan introduced the self-developed WUKONG Automated, Closed, Integrated Cell Processing System, building on its existing modular cell preparation platforms.
Cell Harvesting Market: Recent Efforts in 2025
| National Institutes of Health (NIH) | Coordinated with the Food and Drug Administration (FDA) and implemented a new funding opportunity in 2025 for clinical trials using adult stem cells. |
| National Cancer Institute (NCI) | Continued to fund projects in 2025 that establish biomimetic, tissue-engineered technologies for cancer research. |
| Indian Council of Medical Research (ICMR) | Joined with the Department of Biotechnology (DBT) to develop new guidelines in May 2025 for the ethical and safe use of stem cells. |
| European Medicines Agency (EMA) | Recommended conditional market authorization for Zemcelpro, a stem cell therapy for adults with certain blood cancers |
Segmental Insights
By product type analysis
Which Product Type Led the Cell Harvesting Market in 2024?
The devices & instruments segment accounted for the largest share of the market in 2024. This mainly comprises automated systems, centrifuges, incubators, and cryostorage equipment. Currently, the market is bolstering integration of robotic systems, such as the CellXpress Automated Cell Culture System and the AUTOSTEM platform combines liquid handlers, incubators, imagers, and robotics to handle the comprehensive cell culture workflow. Also, they are imposing the evolution of enclosed, single-use systems for preventing contamination.
On the other hand, the consumables segment is estimated to expand at a rapid CAGR. This primarily uses diverse reagents, media, cryopreservation agents, and single-use processing equipment. Ongoing efforts are supporting a shift from serum-containing media to serum-free, xeno-free, and chemically defined media. Alongside, the market is stepping into single-use, disposable consumables, the wider adoption of GMP-grade consumables, and the use of cryovials and cryobags developed for low-temperature freezing.
Get the latest insights on life science industry segmentation with our Annual Membership:By cell type analysis
What Made the Mammalian Cells Segment Dominant in the Market in 2024?
The mammalian cells segment held the biggest share of the cell harvesting market in 2024. The widespread need for therapeutic proteins, biosimilars, and vaccinesHowever, the stem cells segment will expand rapidly during 2025-2034. An expanding demand for personalized medicine, broader investment in the field, and a growth in clinical trials and public awareness of stem cell therapies are propelling the overall adoption. These cell harvests consist of less invasive sourcing of iPSCs from reprogrammed adult cells, and a novel plan to increase hematopoietic stem cell (HSC) yields by recognizing and manipulating macrophage-like markers on stem cells.
By application type analysis
Which Application Type Led the Cell Harvesting Market in 2024?
The biopharmaceutical production segment registered dominance with a dominant share of the market in 2024. A rise in applications of cell harvesting in immunotherapy, eventually for cancer treatments like CAR-T cell therapy In the future, the cell & gene therapy manufacturing segment is predicted to witness rapid expansion. The rising cases of cancer, autoimmune disorders, and genetic diseases are fueling the wider demand for these therapies. These companies are widely exploring fully automated platforms with integration of the harvest step into the overall process, lowering manual intervention and optimizing consistency. These manufacturing approaches employ automated microfluidic platformsBy technique type analysis
Why did the Centrifugation-Based Harvesting Segment Dominate the Market in 2024?
In the cell harvesting market, the centrifugation-based harvesting segment held a major share in 2024. The segment is fueled by the increasing advances in single-use centrifuge systems are which have promising advantages, such as consistency, scalability, and minimized waste as compared to traditional systems. Although the major players are implementing their breakthroughs in counterflow centrifugation for gentler cell separation with enhanced viabilityOn the other hand, the automated & closed system harvesting segment is anticipated to expand fastest. The escalating need for enhanced reproducibility and yield, minimal contamination risk and labor expenses, scalability for large-scale manufacturing, and advances in automation technologies like AI and machine learning are propelling the segmental growth. The latest development includes Miltenyi Biotec's CliniMACS Prodigy and Lonza's Cocoon to achieve cell isolation, activation, expansion, and formulation within a single, completely closed system.
By end user analysis
How did the Biopharmaceutical & Biotechnology Companies Segment Dominate the Market in 2024?
The biopharmaceutical & biotechnology companies segment registered dominance in the global cell harvesting market in 2024. The segment is driven by a rise in demand for cell-based therapies, the requirement for automated and high-throughput systems in late-stage drug trials, and commercial manufacturing. They are highly using integrated AI and machine learning for process improvements, the development of next-generation technologies, including fiber chromatography, and the wider adoption of single-use systems.
Whereas, the cell therapy companies & CDMOs segment is estimated to expand at a rapid CAGR in the coming era. Primarily, CDMOs are offering integrated solutions to handle the comprehensive workflow from cell modification to final product formulation. They are putting efforts into advanced digital solutions that are further employed for real-time data sharing among manufacturing teams and clients. Moreover, they are providing expertise, sophisticated technology, and manufacturing capacity in managing both development and large-scale production.
Browse More Insights of Towards Healthcare:
The global cell culture microcarriers market
The global cell migration and cell invasion assay market size
The global cell culture vessels market
The global cell culture collagen market
The global cell & gene therapy logistics market
The global cell and gene therapy CRO market
The global cell and gene overexpression service market
The global cell and gene therapy thawing equipment market
The global cell therapy raw materials market
The global cell separation technologies market
What are the Recent Developments in the Cell Harvesting Market?
- In October 2025, Allied Pain & Spine Institute (APSI), a leading provider of comprehensive musculoskeletal and interventional care, launched OrthoGen Health, an innovative regenerative medicine division. In October 2025, PromoCell, a leading global manufacturer of primary human cells and specialized cells, unveiled custom GMP cell culture media to empower next-gen cell and gene therapies. In August 2025, the IAEA unveiled a new stem cell research project to optimize healing for patients suffering from severe radiation skin injuries.
Cell Harvesting Market Key Players List
- Thermo Fisher Scientific Inc. Merck KGaA (MilliporeSigma) GE HealthCare (Cytiva) Sartorius AG Eppendorf SE BD Biosciences Terumo BCT, Inc. Beckman Coulter Life Sciences (Danaher) Miltenyi Biotec GmbH Fresenius Kabi (CompoFlex & LOVO systems) Corning Incorporated Lonza Group AG Repligen Corporation Asahi Kasei Medical Co., Ltd. Stemcell Technologies Inc. PerkinElmer Inc. (Revvity) Bio-Rad Laboratories, Inc. PBS Biotech, Inc. Terumo Corporation Applikon Biotechnology (a Getinge company)
Segments Covered in the Report
By Product Type
- Devices & Instruments Centrifuges Automated cell harvesters Cell separators Filters & membrane-based systems Consumables Harvesting kits Tubing & disposables Reagents & enzymes
By Cell Type
- Stem Cells Mesenchymal stem cells Hematopoietic stem cells Induced pluripotent stem cells (iPSCs) Mammalian Cells CHO cells, HEK293, Vero cells (for biologics & vaccine production) Immune Cells T-cells, NK cells, B-cells (for immunotherapies) Microbial & Plant Cells Algae, yeast, bacteria (used in nutraceuticals & industrial biotech)
By Application
- Biopharmaceutical Production Monoclonal antibodies Recombinant proteins Cell & Gene Therapy Manufacturing Cancer & Immunology Research Stem Cell Research & Regenerative Medicine Vaccine Production Tissue Engineering
By Technique
- Centrifugation-Based Harvesting Filtration-Based Harvesting Automated & Closed System Harvesting Microfluidics & Membrane-Based Separation Magnetic Separation (for immune cells & precision harvesting)
By End User
- Biopharmaceutical & Biotechnology Companies Cell Therapy Companies & CDMOs Academic & Research Institutions Contract Research Organizations (CROs) Hospitals & Transplant Centers
By Region
- North America
- U.S. Canada
- China Japan India South Korea Thailand
- Germany UK France Italy Spain Sweden Denmark Norway
- Brazil Mexico Argentina
- South Africa UAE Saudi Arabia Kuwait
Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard:About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research You can place an order or ask any questions, please feel free to contact us at ...Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web:Our Trusted Data Partners
Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment